| 1 |
35204223 | Pre-Exposure to Stress-Inducing Agents Increase the Anticancer Efficacy of Focused Ultrasound against Aggressive Prostate Cancer Cells. | 2022 Feb 9 |
1 |
| 2 |
35387819 | Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial. | 2022 Apr 6 |
1 |
| 3 |
34136086 | Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type. | 2021 Jun 8 |
2 |
| 4 |
28137980 | Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells. | 2017 Mar |
2 |
| 5 |
27280849 | Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells. | 2016 |
4 |
| 6 |
24418752 | Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations. | 2014 Mar |
1 |
| 7 |
25327558 | A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors. | 2014 Sep 30 |
1 |
| 8 |
23647753 | Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer. | 2013 May |
1 |
| 9 |
22271897 | The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo. | 2012 Jul |
1 |
| 10 |
22338016 | Akt inhibitors MK-2206 and nelfinavir overcome mTOR inhibitor resistance in diffuse large B-cell lymphoma. | 2012 May 1 |
3 |
| 11 |
19480971 | Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT. | 2009 Jul 1 |
1 |
| 12 |
18000394 | Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy. | 2008 Jan |
1 |
| 13 |
18509182 | Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer. | 2008 Jun 1 |
1 |
| 14 |
17460771 | The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response. | 2007 Apr |
3 |
| 15 |
17483362 | Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir. | 2007 May 1 |
3 |
| 16 |
17785575 | Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. | 2007 Sep 1 |
1 |
| 17 |
17132220 | HIV protease inhibitors decrease VEGF/HIF-1alpha expression and angiogenesis in glioblastoma cells. | 2006 Nov |
1 |
| 18 |
17133272 | NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines. | 2006 Dec 18 |
1 |
| 19 |
16166302 | HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo. | 2005 Sep 15 |
2 |
| 20 |
15168016 | Nelfinavir-induced insulin resistance is associated with impaired plasma membrane recruitment of the PI 3-kinase effectors Akt/PKB and PKC-zeta. | 2004 Jun |
1 |